Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Policy Forum Jan 2007 Is It Ethical to Send Patients to Low-Volume Hospitals for Cancer Surgery? Timothy M. Pawlik, MD, MPH and Kenneth K. Tanabe, MD Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007;9(1):44-47. doi: 10.1001/virtualmentor.2007.9.1.pfor2-0701.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Policy Forum Jan 2007 Is It Ethical to Send Patients to Low-Volume Hospitals for Cancer Surgery? Timothy M. Pawlik, MD, MPH and Kenneth K. Tanabe, MD Two physicians examine the history of cancer drug pricing and the barriers to setting fair prices for life-saving cancer medications. Virtual Mentor. 2007;9(1):44-47. doi: 10.1001/virtualmentor.2007.9.1.pfor2-0701.